Chardan Capital Maintains Ocugen (OCGN) Buy Recommendation

Fintel reports that on April 14, 2023,
Chardan Capital
coverage of Ocugen (NASDAQ:OCGN) with
a Buy recommendation.

Analyst Price Forecast Suggests 516.09% Upside

As of April 7, 2023,
the average one-year price target for Ocugen is $4.93.
The forecasts range from a low of $3.03 to a high of $8.40.
The average price target represents an increase of 516.09% from its latest reported closing price of $0.80.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Ocugen

Read more…

Request a Call Back

Contact Info